26 مايو #efficacy #MENA #pazopanib #real-life experience #safety #second-line #soft tissue sarcoma Safety and efficacy of pazopanib as a second-line treatment and beyond for soft tissue sarcomas: A real-life tertiary-center experience in the MENA region by Dr. Fadi Farhat 0
05 يناير #adjuvant #Chemotherapy #Cost-Effectiveness #Impact #Oncotype DX Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer by Dr. Fadi Farhat 0
29 نوفمبر #adjuvant #Commercialized #Decision #Early-Stage Breast Cancer #Genomic #Impact Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients by Dr. Fadi Farhat 0
06 نوفمبر #Avelumab #Chemotherapy #Neoadjuvant Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer by Dr. Fadi Farhat 0
15 أكتوبر #breast cancer #case report #invasive ductal carcinoma #Rare #renal carcinoma #review Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behavior: a case report with a literature review by Dr. Fadi Farhat 0
21 سبتمبر #Cancer #Opioid #Pain #Pilot Study #South Lebanon Current Status of Cancer-Related Pain and Opioid use in South Lebanon: A Pilot Study by Dr. Fadi Farhat 0
01 سبتمبر #CDK4/6inhibitors #Liposarcoma Targeting CDK4 (cyclin dependent kinase) amplification in liposarcoma: A comprehensive review by Dr. Fadi Farhat 0
31 يوليو #Epithelioid sarcoma #personalized therapy #soft tissue sarcoma Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma by Dr. Fadi Farhat 0
03 مايو #Docetaxel #Metastatic Prostate Cancer #review Docetaxel Re-challenge in Patients with Metastatic Prostate Cancer: A Comprehensive Review by Dr. Fadi Farhat 0
19 أبريل #Rare Comprehensive tumor profiling-guided therapy in rare or refractory solid cancer: A feasibility study in daily clinical practice by Dr. Fadi Farhat 0
